Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Chenxi Xie, Xiaopei Hao, Hao Yuan, Chongyu Wang, Razinah Sharif & Haibo Yu. (2024) Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications. OncoTargets and Therapy 17, pages 7-26.
Read now
Read now
Jia-Wei Xu, Bu-Sen Wang, Ping Gao, Hai-Tao Huang, Fei-Yu Wang, Wei Qiu, Yuan-Yuan Zhang, Yu Xu, Jin-Bo Gou, Lin-Ling Yu, Xuan Liu, Rui-Jie Wang, Tao Zhu, Li-Hua Hou & Qing- Wang. (2024) Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial. Emerging Microbes & Infections 13:1.
Read now
Read now
Shant H. Mahrokhian, Lisa H. Tostanoski, Samuel J. Vidal & Dan H. Barouch. (2024) COVID-19 vaccines: Immune correlates and clinical outcomes. Human Vaccines & Immunotherapeutics 20:1.
Read now
Read now
Shen-Yu Wang, Wen-Qing Liu, Yu-Qing Li, Jing-Xin Li & Feng-Cai Zhu. (2023) A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov. Expert Review of Vaccines 22:1, pages 704-713.
Read now
Read now
Yuping Duan, Mingyue Jiang, Luodan Suo, Mingyu Xu, Xiaomei Li, Qing Wang, Chengxu Bai, Jiang Wu, Zheng Xu, Weizhong Yang, Luzhao Feng & Juan Li. (2023) Evaluating the accessibility and capacity of SARS-CoV-2 vaccination and analyzing convenience-related factors during the Omicron variant epidemic in Beijing, China. Human Vaccines & Immunotherapeutics 19:3.
Read now
Read now
Ileana García-Silva, Dania O Govea-Alonso & Sergio Rosales-Mendoza. (2023) Current status of mucosal vaccines against SARS-CoV2: a hope for protective immunity. Expert Opinion on Biological Therapy 23:2, pages 207-222.
Read now
Read now
Articles from other publishers (21)
Gao Song, Rong Li & Meng‐qun Cheng. (2024) Safety, immunogenicity, and protective effective of inhaled COVID‐19 vaccines: A systematic review and meta‐analysis. Journal of Medical Virology 96:4.
Crossref
Crossref
Yi-Bing Lian, Man-Jie Hu, Tian-Kui Guo, Yong-Lei Yang, Rong-Rong Zhang, Jing-Shu Huang, Ling-Jiao Yu, Chun-Wei Shi, Gui-Lian Yang, Hai-Bin Huang, Yan-Long Jiang, Jian-Zhong Wang, Xin Cao, Nan Wang, Yan Zeng, Wen-Tao Yang & Chun-Feng Wang. (2024) The protective effect of intranasal immunization with influenza virus recombinant adenovirus vaccine on mucosal and systemic immune response. International Immunopharmacology 130, pages 111710.
Crossref
Crossref
Li Qin, Yanhua Sun, Nan Gao, Guixia Ling & Peng Zhang. (2023) Nanotechnology of inhalable vaccines for enhancing mucosal immunity. Drug Delivery and Translational Research 14:3, pages 597-620.
Crossref
Crossref
Zhigang Zheng, Huimin Wu, Xiaowei Sun, Yefeng Lu, Yanyan Song, Yi Luo, Tao Zhou, Mingxuan Feng, Ping Wan, Jianjun Zhu, Nan Shen, Qing Cao, Ji Liang, Qiang Xia & Feng Xue. (2024) Evaluation of the effectiveness and safety of sequential vaccination with inactivated SARS‐CoV‐2 vaccine and Ad5‐nCoV booster in pediatric liver transplant recipients. Journal of Medical Virology 96:3.
Crossref
Crossref
Yufeng Song, Frances Mehl & Steven L. Zeichner. (2024) Vaccine Strategies to Elicit Mucosal Immunity. Vaccines 12:2, pages 191.
Crossref
Crossref
Katherine McMahan, Frank Wegmann, Malika Aid, Michaela Sciacca, Jinyan Liu, Nicole P. Hachmann, Jessica Miller, Catherine Jacob-Dolan, Olivia Powers, David Hope, Cindy Wu, Juliana Pereira, Tetyana Murdza, Camille R. Mazurek, Amelia Hoyt, Adrianus C. M. Boon, Meredith Davis-Gardner, Mehul S. Suthar, Amanda J. Martinot, Mona Boursiquot, Anthony Cook, Laurent Pessaint, Mark G. Lewis, Hanne Andersen, Jeroen Tolboom, Jan Serroyen, Laura Solforosi, Lea M. M. Costes, Roland C. Zahn & Dan H. Barouch. (2023) Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques. Nature 626:7998, pages 385-391.
Crossref
Crossref
Fu-Zhen Wang, Chun-Huan Zhang, Lin Tang, Lance E Rodewald, Wen Wang, Si-Yu Liu, Wen-Ji Wang, Dan Wu, Qian-Qian Liu, Xiao-Qi Wang, Li-Fang Huang, Ao-Di Huang, Li-Ming Bao, Zhou-Bin Zhang & Zun-Dong Yin. (2024) An Observational Prospective Cohort Study of Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection of an Aerosolized, Inhaled Adenovirus Type 5–Vectored Coronavirus Disease 2019 Vaccine Given as a Second Booster Dose in Guangzhou City, China. The Journal of Infectious Diseases 229:1, pages 117-121.
Crossref
Crossref
Qiuxue Han, Shen Wang, Zhenshan Wang, Cheng Zhang, Xinyue Wang, Na Feng, Tiecheng Wang, Yongkun Zhao, Hang Chi, Feihu Yan & Xianzhu Xia. (2023) Nanobodies with cross-neutralizing activity provide prominent therapeutic efficacy in mild and severe COVID-19 rodent models. Virologica Sinica 38:5, pages 787-800.
Crossref
Crossref
Haohang Wang, Mingting Cui, Shunran Li, Fan Wu, Shiqiang Jiang, Hongbiao Chen, Jianhui Yuan & Caijun Sun. (2023) Perception and willingness toward various immunization routes for COVID-19 vaccines: a cross-sectional survey in China. Frontiers in Public Health 11.
Crossref
Crossref
Shen Wang, Mian Qin, Long Xu, Ting Mu, Ping Zhao, Bing Sun, Yue Wu, Lingli Song, Han Wu, Weicheng Wang, Xingwen Liu, Yanyan Li, Fengmei Yang, Ke Xu, Zhanlong He, Michel Klein & Ke Wu. (2023) Aerosol Inhalation of Chimpanzee Adenovirus Vectors (ChAd68) Expressing Ancestral or Omicron BA.1 Stabilized Pre–Fusion Spike Glycoproteins Protects Non–Human Primates against SARS-CoV-2 Infection. Vaccines 11:9, pages 1427.
Crossref
Crossref
Sam Afkhami, Alisha Kang, Vidthiya Jeyanathan, Zhou Xing & Mangalakumari Jeyanathan. (2023) Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19. Current Opinion in Virology 61, pages 101334.
Crossref
Crossref
Tao Huang, Sheng Zhang, De-Fang Dai, Bu-Sen Wang, Lu Zhuang, Hai-Tao Huang, Zhong-Fang Wang, Jun-Shi Zhao, Qiu-Ping Li, Shi-Po Wu, Xue Wang, Wen-Dan Zhang, Zheng-Hao Zhao, Hao Li, Yan-Ping Zhang, Xiu-Liang Yang, Xin-Yang Jiang, Jin-Bo Gou, Li-Hua Hou, Li-Dong Gao & Zhi-Chun Feng. (2023) Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre study. The Lancet Respiratory Medicine 11:8, pages 698-708.
Crossref
Crossref
Yan-Feng Sun, Yuming Guo, Chi Xu, Ying Liu, Xu Zhao, Qian Liu, Erik Jeppesen, Haijun Wang & Ping Xie. (2023) Will “Air Eutrophication” Increase the Risk of Ecological Threat to Public Health?. Environmental Science & Technology 57:29, pages 10512-10520.
Crossref
Crossref
Letian Li, Jiayi Hao, Yuhang Jiang, Pengfei Hao, Yuwei Gao, Jing Chen, Guoqing Zhang, Ningyi Jin, Maopeng Wang & Chang Li. (2023) A micro-sized vaccine based on recombinant Lactiplantibacillus plantarum fights against SARS-CoV-2 infection via intranasal immunization. Acta Pharmaceutica Sinica B 13:7, pages 3168-3176.
Crossref
Crossref
Bin Tu, Yanrong Gao, Xinran An, Huiyuan Wang & Yongzhuo Huang. (2023) Localized delivery of nanomedicine and antibodies for combating COVID-19. Acta Pharmaceutica Sinica B 13:5, pages 1828-1846.
Crossref
Crossref
Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, Rebecca Farkas, Shobana Balasingam, Karin Bok, Ursula J. Buchholz, M. Patricia D’Souza, Jennifer L. Gordon, Deborah F. L. King, Tung T. Le, Wolfgang W. Leitner, Robert A. Seder, Alkis Togias, Stig Tollefsen, David W. Vaughn, Daniel N. Wolfe, Kimberly L. Taylor & Anthony S. Fauci. (2023) Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report. npj Vaccines 8:1.
Crossref
Crossref
Shen Wang, Bo Liang, Weiqi Wang, Ling Li, Na Feng, Yongkun Zhao, Tiecheng Wang, Feihu Yan, Songtao Yang & Xianzhu Xia. (2023) Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Xiyue He, Xiaoyan Chen, Hairui Wang, Guangsheng Du & Xun Sun. (2023) Recent advances in respiratory immunization: A focus on COVID-19 vaccines. Journal of Controlled Release 355, pages 655-674.
Crossref
Crossref
Michael Yee-Tak Chow & Jenny Ka Wing Lam. 2023. Respiratory Delivery of Biologics, Nucleic Acids, and Vaccines. Respiratory Delivery of Biologics, Nucleic Acids, and Vaccines
123
148
.
Jing-Xin Li, Shi-Po Wu, Xi-Ling Guo, Rong Tang, Bao-Ying Huang, Xiao-Qin Chen, Yin Chen, Li-Hua Hou, Jing-Xian Liu, Jin Zhong, Hong-Xing Pan, Feng-Juan Shi, Xiao-Yu Xu, Zhuo-Pei Li, Xiao-Yin Zhang, Lun-Biao Cui, Wen-Jie Tan, Wei Chen, Feng-Cai Zhu, Jing-Xin Li, Shi-Po Wu, Xi-Ling Guo, Rong Tang, Bao-Ying Huang, Xiao-Qin Chen, Yin Chen, Li-Hua Hou, Jing-Xian Liu, Jin Zhong, Hong-Xing Pan, Feng-Juan Shi, Xiao-Yu Xu, Zhuo-Pei Li, Xiao-Yin Zhang, Lun-Biao Cui, Wen-Jie Tan, Wei Chen, Feng-Cai Zhu, Hai-Tao Huang, Jin-Bo Gou, Wei-Xue Si, Xue Wang, Xiao-Long Zhao & Tao Zhu. (2022) Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial. The Lancet Respiratory Medicine 10:8, pages 739-748.
Crossref
Crossref
Tatianna Travieso, Jenny Li, Sneha Mahesh, Juliana Da Fonzeca Redenze E. Mello & Maria Blasi. (2022) The use of viral vectors in vaccine development. npj Vaccines 7:1.
Crossref
Crossref